Seminars in breast disease最新文献_第9页

Computed Radiography for Mammography: Operational Perspectives 乳腺x线摄影的计算机x线摄影:操作角度

Seminars in breast disease Pub Date : 2006-06-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.12.003

R. James Brenner MD

引用次数: 1

Full-Field Digital Mammography Quality Control: Operational Considerations 全视场数字乳房x线摄影质量控制:操作考虑

Seminars in breast disease Pub Date : 2006-06-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.12.004

Jay R. Parikh MD, FRCP(c), CPE, FSBI, FACPE , Priscilla F. Butler MS, FACR, FAAPM

引用次数: 0

Full-Field Digital Mammography Workflow 全视场数字乳房x线摄影工作流程

Seminars in breast disease Pub Date : 2006-06-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.12.005

Margarita Zuley MD , Jay R. Parikh MD, FRCP(c), CPE, FSBI, FACPE

引用次数: 4

The Power of Partnership: Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics to Community Breast Care Centers 伙伴关系的力量:将临床癌症遗传学的综合癌症中心专业知识扩展到社区乳房护理中心

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.001

Deborah J. MacDonald , Sharon Sand , Frederic Kass , Kathleen R. Blazer , Jane Congleton , John Craig , Jeffrey N. Weitzel

{"title":"The Power of Partnership: Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics to Community Breast Care Centers","authors":"Deborah J. MacDonald , Sharon Sand , Frederic Kass , Kathleen R. Blazer , Jane Congleton , John Craig , Jeffrey N. Weitzel","doi":"10.1053/j.sembd.2006.10.001","DOIUrl":"10.1053/j.sembd.2006.10.001","url":null,"abstract":"<div><p><span>Although many academic medical centers provide comprehensive genetic cancer risk assessment (GCRA) services, most people receive their medical care in the community setting. Consequently, the City of Hope Comprehensive Cancer Center in Southern California developed a hub and spoke </span><em>Cancer Screening & Prevention Program Network<sup>sm</sup></em><span> (CSPPN) to facilitate the delivery of state of the art GCRA services in dispersed communities. Growth of the CSPPN and innovation in technical support was catalyzed by education research grants and a technology transfer grant. An extended informatics technology-enabled network strategy was crafted, wherein community-based breast centers contract with the Cancer Center for program development, specialized training for personnel and ongoing support for quality care, and continuing medical education for community clinicians. Technology and collaboration are a powerful way to extend GCRA expertise from a NCI-designated Comprehensive Cancer Center to community breast centers, with a net effect of increased access to expertise and enhanced community-based research.</span></p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"9 1","pages":"Pages 39-47"},"PeriodicalIF":0.0,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2006.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57938075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Breast Cancer Ablation: Current Status 2006 乳腺癌消融:2006年现状

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.004

Cary S. Kaufman MD, FACS

引用次数: 0

Neoadjuvant Therapy: The Ultimate Interdisciplinary Challenge 新辅助治疗:跨学科的终极挑战

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.002

John S. Link , Jane L. Kakkis , Richard Reitherman , Julio A. Ibarra , Cheryl I. Jacobs

引用次数: 0

New Directions in Radiation for Breast Conserving Therapy in Early Stage Breast Cancer 早期乳腺癌保乳放疗的新方向

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.007

Julia White MD

引用次数: 0

As the Median Size of Invasive Breast Cancers at Time of Diagnosis Continues to Fall, How Does the Oncologist Guard Against Over-Treatment? 随着浸润性乳腺癌在诊断时的中位体积持续下降，肿瘤学家如何防范过度治疗?

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.003

Peter M. Ravdin PhD, MD

{"title":"As the Median Size of Invasive Breast Cancers at Time of Diagnosis Continues to Fall, How Does the Oncologist Guard Against Over-Treatment?","authors":"Peter M. Ravdin PhD, MD","doi":"10.1053/j.sembd.2006.10.003","DOIUrl":"10.1053/j.sembd.2006.10.003","url":null,"abstract":"<div><p>Because of mammographic screening, the most common presentation of breast cancer is now as Stage 1 disease. These patients have on average a low risk of recurrence and death due to their primary cancer of about 10% on average. Most of these patients will never relapse and, therefore, to treat all these patients is clearly less than ideal. Unfortunately, current clinical and pathologic information cannot reliably identify who is destined to relapse. For most of these patients, therefore, a decision needs to be made about whether and what type of adjuvant therapy should be given. For many of these low-risk patients, it is often not obvious what the balance is between the benefit of adjuvant therapy (which on average will be small) versus its risks and costs. There are various approaches to making these decisions, but present day guidelines are not entirely satisfactory, because although they are evidence based, they often lack quantitative information. This leaves the patient and her physician unable to reweigh the evidence for themselves, and this is not informed decision making. Decision tools are playing ever greater roles in medicine. Even more so than guidelines, they can give individualized estimates. Furthermore, they also can provide individualized quantitative information. Decision tools, like guidelines, have limitations in that they are only as strong as the data on which they are based, and it is important that they acknowledge areas of controversy and conflicted views about the interpretation of the data. Some of the issues involved in the use of decision tools are illustrated in a discussion of the tool Adjuvant!. These tools now are using classical clinical and pathologic parameters, but have the potential to incorporate parameters from the new multigene molecular tests.</p></div>","PeriodicalId":87785,"journal":{"name":"Seminars in breast disease","volume":"9 1","pages":"Pages 25-29"},"PeriodicalIF":0.0,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sembd.2006.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"57938183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

A Molecular Profiling of Breast Cancer 乳腺癌的分子图谱

Seminars in breast disease Pub Date : 2006-03-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.10.005

Jeff Seebach MD , Rachel E. Ellsworth PhD , Craig D. Shriver MD, FACS

引用次数: 3

Impact of ACRIN DMIST Results on the Technologist and Mammography Practice ACRIN DMIST结果对技术人员和乳腺造影实践的影响

Seminars in breast disease Pub Date : 2005-12-01 Epub Date: 2008-09-25 DOI: 10.1053/j.sembd.2006.08.004

R. Edward Hendrick PhD, FACR

引用次数: 3